This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Karl Mannhardt: Innovator in Pharmaceutical Chemistry
Introduction
Karl Mannhardt is a notable inventor based in Elzach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of blood vessel diseases. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Mannhardt holds a patent for "1-6-naphthyridine derivatives useful in the treatment of blood vessel." This invention describes 1,6-naphthyridine derivatives of a specific general formula, wherein various substituents are defined to enhance the pharmacological properties of the compounds. These derivatives are designed to be pharmacologically acceptable salts, which are beneficial for treating diseases related to blood vessels. His patent represents a significant advancement in the search for effective treatments in this medical area. He has 1 patent to his name.
Career Highlights
Throughout his career, Karl Mannhardt has focused on the synthesis and application of novel chemical compounds. His work has been instrumental in advancing the understanding of how specific chemical structures can influence biological activity. Mannhardt's dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Mannhardt has collaborated with notable colleagues such as Hartmut Osswald and Gunter Weinheimer. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the quality and impact of their collective research efforts.
Conclusion
Karl Mannhardt's contributions to pharmaceutical chemistry, particularly through his patent on 1-6-naphthyridine derivatives, highlight his role as an innovator in the field. His work continues to inspire advancements in medical treatments for blood vessel diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile